Powles, Professor Thomas thomas.powles**[ta]**tsandthelondon.nhs.uk
CRUKE/11/021: PLUTO: Panopanib versus paclitaxel in relapsed urothelial tumours: a randomised phase II study investigating pazopanib versus paclitaxel in relapsed or locally advanced TCC of the
Preston, Mr Shaun CRUK/14/017: Neo-AEGIS - Randomised Clinical Trial of neoadjuvant and adjuvant chemotherapy (MAGIC regimen) vs.neoadjuvant chemoradiation (CROSS protocol) in adenocarcinoma of the oesophagus and oesophago-gastric
Primrose, Professor John CRUK/06/031: New EPOC: peri-operative chemotherapy in patients with resectable colorectal liver metastases - does the addition of an anti-EGF receptor antibody improve progression free survival? (funded by the Bobby Moore Fund)
CRUK/12/048: ORANGE II PLUS trial University of Southampton 01/10/2013
Trans EPOC - Investigating the molecular predictors of response in metastatic colorectal cancer University of Southampton 01/03/2009
Pritchard, Professor Catrin cap8**[ta]**ac.uk
Mechanisms of RAS/RAF-driven oncogenesis University of Leicester 01/10/2011
The above is a list of Cancer Research UK’s active publishable awards as of 30 September 2015.For any further enquiries please contact researcher.comments**[ta]**cer.org.uk.Pritchard-Jones, Professor Kathy A biomarker approach to improving population outcomes for renal tumours of childhood Institute of Child Health and University College London 01/01/2014
Propper, Dr David d.j.propper**[ta]**l.ac.uk
CRUKD/12/011: A Phase I dose escalation trial of HDAC inhibitor CHR2845 for cancer associated inflammation in hepatocellular carcinoma Queen Mary, University of London 01/06/2012
Pule, Dr Martin m.pule**[ta]**.ac.uk
Development of a novel immunotherapeutic for CLL University College London 01/06/2014
Qian, Dr Binzhi binzhi.qian**[ta]**ac.uk
The role(s) of macrophages in breast cancer bone
Quezada, Dr Sergio Defning the mechanisms underpinning the function of regulatory and effector tumour-reactive CD4+ T cells during tumorigenesis: applications to cancer immunotherapy University College London 01/11/2010
Rachet, Dr Bernard Early diagnosis commissioned policy research programme London School of Hygiene and Tropical Medicine 01/04/2014
Rahman, Professor Nazneen rahmanlab**[ta]**.ac.uk
The Clinical Translation of Breast Cancer Predisposition Genes Institute of Cancer Research 01/10/2012
Rajan, Dr Prabhakar p.rajan**[ta]**tson.gla.ac.uk
Analysis of alternative splicing in prostate cancer metastasis regulated by the RNA-binding proteins Sam68 and hnRNP A2/B1 University of Glasgow 01/03/2013
Rao, Dr Sheela CRUK/12/038: InterAAct - A Phase II International Multicentre Randomized Advanced Anal Cancer Trial Comparing Cisplatin plus 5FU vs.Carboplatin plus Weekly Paclitaxel in Patients with Relapsed or Metastatic Disease (International Rare Cancers Initiative
study - IRCI 003) Royal Marsden NHS Foundation Trust 01/06/2014
Ratschen, Dr Elena Treating smoking in mental health inpatient settings - exploring options to implement new NICE
Rea, Dr Daniel d.w.rea**[ta]**m.ac.uk
CRUK/94/001: aTTom: adjuvant Tamoxifen Treatment offer more? Follow-up, Data Cleaning and Analysis University of Birmingham 01/08/2011
The above is a list of Cancer Research
Immunobiology Laboratory The Francis Crick Institute 01/06/2012
Renehan, Professor Andrew Development of a risk prediction tool for early cancer detection in patients with type 2
Renzi, Dr Cristina c.renzi**[ta]**.ac.uk
Missed opportunities for earlier cancer diagnosis along the diagnostic pathway and effect on colorectal cancer diagnosis following emergency presentation: importance of healthcare and patient-related factors University College London 01/12/2014
Riddell, Dr Angela angela.riddell**[ta]**.nhs.uk
High Resolution MR imaging as a predictive biomarker for determining resectability in oesophageal and oesophagogastric cancer University College London 01/10/2011
Riddet, Mr Ian CRUK/11/054: Molecular selection of therapy in metastatic colorectal cancer: a molecularly stratifed randomised controlled trial programme(FOCUS 4) (supported by Stand Up To Cancer)(AZ/NCRN) The Department of Health 01/04/2013
Ridley, Professor Anne anne.ridley**[ta]**.ac.uk
Rho GTPase signalling in cancer invasion and metastasis King's College London 01/01/2013
Ringshausen, Dr Ingo ir279**[ta]**.ac.uk
Characterization of signalling pathways underlying bi-directional communications with the microenvironment in B lymphoproliferative diseases University of Cambridge 01/10/2014
Robb, Dr Katie Katie.Robb**[ta]**sgow.ac.uk
What can we learn about how to improve uptake of bowel cancer screening from higher rates of uptake in breast and cervical screening programmes?
Robinson, Ms Emily erobinson**[ta]**oholconcern.org.uk
Alcohol Advocacy Alcohol Concern 01/06/2015
Health First Advocacy Project Alcohol Concern 01/03/2014
Rocha, Dr Sonia s.rocha**[ta]**dee.ac.uk
Mechanisms of inflammation and hypoxia-induced responses mediated by HIF and NF-kappaB in cancer University of Dundee 01/08/2011
Rosenfeld, Dr Nitzan Molecular and Computational Diagnostics Cancer Research UK Cambridge Institute 01/07/2014
Ross, Professor Richard CRUK/10/012: TRYMS: Testosterone replacement in young male cancer survivors University of Shefeld 01/10/2010
Rowe, Professor Martin m.rowe**[ta]**m.ac.uk
Epstein-Barr virus infections and lymphomagenesis University of Birmingham 01/01/2013
The above is a list of Cancer Research UK’s active publishable awards as of 30 September 2015.For any further enquiries please contact researcher.comments**[ta]**cer.org.uk.Royle, Dr Stephen Molecular mechanisms of kinetochore fbre stabilisation University of Warwick 01/02/2013
Molecular mechanisms of kinetochore fbre stabilisation University of Warwick 01/07/2013
Rubin, Professor Greg g.p.rubin**[ta]**ham.ac.uk
CRUK/14/070: Phase II exploratory randomised controlled trial (RCT) comparing use of electronic clinical decision support (eCDS) for suspected oesophago-gastric cancer in primary care with usual care.The oesophago-gastric risk evaluation (OGRE) trial University of Durham 01/01/2015
Rueda, Dr Oscar Oscar.Rueda**[ta]**k.cam.ac.uk
Characterization of breast tumour evolution and clonal selection in patient-derived xenograft models University of Cambridge 01/09/2015
Rule, Professor Simon simon.rule**[ta]**.net CRUK/14/026: ENRICH - Randomised, Phase II open label study of Rituximab/Ibritinib vs Rituximab/Chemo in older patients with mantle cell lymphoma University of Plymouth 01/01/2015
Ryan, Professor Kevin k.ryan**[ta]**tson.gla.ac.uk
Tumour Cell Death Laboratory Cancer Research UK Beatson Institute 01/12/2011
Sachdeva, Mr Ashwin ashwin.sachdeva**[ta]**il.com The role of mitochondrial DNA mutations in prostate carcinogenesis Newcastle University 01/03/2015
Sahai, Dr Erik erik.sahai**[ta]**ck.ac.uk
Understanding the causes and mechanisms of cancer invasion and metastasis The Francis Crick Institute 01/03/2012
Salbreux, Dr Guillaume QQR The Francis Crick Institute 01/01/2015
Saldanha, Dr Gerald gss4**[ta]**ac.uk
A Blood Test For Melanoma - Detection and Analysis of Tumour-Derived Circulating Free DNA by Deep Sequencing (The MELSEQ Study)
Sansom, Professor Owen o.sansom**[ta]**tson.gla.ac.uk
QQR Cancer Research UK Beatson Institute 01/07/2015
Sanz-Moreno, Dr
Transcriptional programs in melanoma metastasis King's College London 01/01/2011
Sarker, Dr Debashis debashis.sarker**[ta]**.ac.uk
CRUKD/13/003 VIBRANT A Phase I clinical trial with VEGFR antagonist vandetanib combined with 131I-mIBG radiotherapy in patients with neuroendocrine tumours, advanced phaeochromocytoma and paraganglioma University College London 01/06/2013
The above is a list of Cancer Research
Cancer screening & statistics Queen Mary, University of London 01/04/2014
Cancer Prevention Trials Unit (CPTU) Queen Mary,
Scafdi, Dr Paola paola.scafdi**[ta]**ck.ac.uk
Identifcation of Epigenetic Mechanisms regulating Cancer Stem Cell Formation and Function The Francis Crick Institute 01/02/2015
Cancer Epigenetics Laboratory The Francis Crick Institute 01/01/2014
Scarisbrick, Dr Julia julia.scarisbrick**[ta]**.nhs.uk
A Multicentre Prospective Study in Mycosis Fungoides and Sezary Syndrome To Develop an International Prognostic Index University Hospital Birmingham NHS Foundation Trust 01/06/2015
Schmid, Professor Peter p.schmid**[ta]**l.ac.uk
CRUKE/12/051: PAKT - A Phase II, randomized, placebo-controlled study of paclitaxel in combination with the Akt inhibitor AZD
CRUKE/12/053: A phase III randomized study of PH (Paclitaxel and Trastuzumab) versus PHL (Paclitaxel, Trastuzumab and Lapatinib) in frst line treatment of HER2 positive metastatic breast
CRUKDE/14/010 TORCMEK A Phase Ib/IIa study of AZD
Schofeld, Professor Christopher christopher.schofeld**[ta]**m.ox.ac.uk
Biochemical and Cellular Characterisation of
Schug, Dr Zachary z.schug**[ta]**tson.gla.ac.uk
Targeting Acetyl CoA Synthetase (ACSS2) and in vivo probing of acetate metabolism in the treatment and diagnosis of colon, breast and prostate cancer Cancer Research UK Beatson Institute 01/01/2015
Sebag-Montefore, Professor David d.sebag-montefore**[ta]**ds.ac.uk
CRUK/08/032: ARISTOTLE: A phase III trial comparing standard versus novel CRT as pre-operative treatment for MRI defned locally advanced rectal cancer (funded by the Bobby Moore Fund for Cancer Research UK) University College London 01/01/2010
CRUK/15/007: PLATO - PersonaLising Anal cancer radioTherapy dOse - incorporating ACT 3, ACT 4 and ACT 5 trials (supported by Stand Up To Cancer) University of Leeds 01/06/2015
The above is a list of Cancer Research UK’s active publishable awards as of 30 September 2015.For any further enquiries please contact researcher.comments**[ta]**cer.org.uk.Seckl, Professor Michael CRUKD/11/004: RADICAL a First in Man Phase I/IIa study of AZD4547, an FGFR inhibitor, in combination with a non-steroidal aromatase inhibitor (anastrozole or letrozole) in ER+ advanced breast cancer patients Imperial College London 01/05/2011